12 acute GDEs to receive share of ÂŁ200m investment for cancer tech
Twelve of the acute Global Digital Exemplars (GDEs) are to receive a share of ÂŁ200m investment to upgrade cancer testing and detection technology.
Back to Top
Twelve of the acute Global Digital Exemplars (GDEs) are to receive a share of ÂŁ200m investment to upgrade cancer testing and detection technology.
Charities and universities have teamed up to form the International Alliance for Cancer Early Detection to develop new strategies for detecting cancer.
The Sensyne Health CEO was asked at Giant Health whether he thought the public would become “more relaxed” about sharing their health data.
Three industries, genomics; digital health; and early diagnosis be critical to the UK continuing to lead in the field of life sciences, Sir John Bell said.
Nearly half of UK healthcare leaders reported that their organisation used artificial intelligence, reflecting an 8% increase compared to 2018.
The centre will draw data from NHS medical records, national registries and other datasets to explore new therapies and medical breakthroughs.